Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
British Journal of Haematology|October 19, 2024
Comparative outcomes of various transplantation platforms, highlighting haploidentical transplants with post-transplantation cyclophosphamide for adult T-cell leukaemia/lymphomaMakoto Yoshimitsu, Takashi Tanaka, Nobuaki Nakano, et al.
Cytotherapy|December 3, 2024
Allogeneic hematopoietic stem cell transplantation using reduced intensity conditioning regimen for patients with acute myeloid leukemia not in complete remissionYoshimitsu Shimomura, Tetsuhisa Kitamura, Masamitsu Yanada, et al.
British Journal of Haematology|October 11, 2021
Clinical significance of the immunoglobulin G heavy-chain repertoire in peripheral blood mononuclear cells of adult T-cell leukaemia-lymphoma patients receiving mogamulizumabKisato Nosaka, Shigeru Kusumoto, Nobuaki Nakano, et al.
American Journal of Hematology|May 1, 2025
Improved Transplant Outcomes With Alternative Donors in Myelofibrosis: A 20-Year Japanese Registry Analysis of Donor Sources and the Impact of RuxolitinibKazuki Sakatoku, Hirohisa Nakamae, Makoto Murata, et al.
European Journal of Haematology|February 22, 2023
Identification of putative noncanonical driver mutations in patients with essential thrombocythemiaAkihiko Arai, Makoto Yoshimitsu, Maki Otsuka, et al.
Blood|November 15, 2014
Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease acceleratorTakuro Kameda, Kotaro Shide, Takumi Yamaji, et al.
Transplantation and Cellular Therapy|July 5, 2025
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Myeloid Malignancies Over 70 Years Old: A Retrospective Analysis of the Japanese Nationwide RegistrySumiko Kobayashi, Hidehiro Itonaga, Shuhei Kurosawa, et al.
British Journal of Haematology|July 17, 2025
A win ratio approach for comparing graft-versus-host disease-free, relapse-free survival among alternative donorsYoshimitsu Shimomura, Sho Komukai, Tetsuhisa Kitamura, et al.
British Journal of Haematology|June 26, 2020
Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105)Dai Maruyama, Shinsuke Iida, Gakuto Ogawa, et al.
American Journal of Hematology|November 20, 2024
Different impacts of granulocyte colony-stimulating factor administration on allogeneic hematopoietic cell transplant outcomes for adult acute myeloid leukemia according to graft typeTakaaki Konuma, Kazuaki Kameda, Kaoru Morita, et al.
Pageof 14